The Management of Pregnancy in Women with ... - Dr Paul P Fogarty

CONTENTS
PARTICIPANTS IN THE DEVELOPMENT OF THIS GUIDELINE .......................................................... 3
1. INTRODUCTION ............................................................................................................................................ 4
1.1 WHY A CLINICAL PRACTICE GUIDELINE ON THE MANAGEMENT OF PREGNANCY IN WOMEN WITH
EPILEPSY?............................................................................................................................................................. 4
1.2 WHO HAS DEVELOPED THIS GUIDELINE?.................................................................................................... 4
1.3 FOR WHOM IS THIS GUIDELINE INTENDED? ................................................................................................ 4
1.4 WHAT METHODS HAVE BEEN USED IN THE DEVELOPMENT OF THIS GUIDELINE?................................ 4
1.5 HOW WILL THIS GUIDELINE BE IMPLEMENTED AND REVIEWED? ............................................................. 6
1.6 DECLARATION OF INTERESTS ...................................................................................................................... 6
2. THE GUIDELINE........................................................................................................................................... 7
2.1 PRE-PREGNANCY CARE AND COUNSELLING.............................................................................................. 7
2.2 FOLIC ACID ...................................................................................................................................................... 9
2.3 VITAMIN K......................................................................................................................................................... 9
2.4 MANAGEMENT OF WOMEN AT RISK OF PRETERM DELIVERY ................................................................. 10
2.5 ANTICONVULSANT DRUGS BEFORE AND DURING PREGNANCY............................................................ 11
2.6 MONITORING AND ADJUSTMENT OF DOSAGE OF ANTICONVULSANTS DURING PREGNANCY ......... 12
2.7 ANTENATAL CARE ........................................................................................................................................ 13
2.8 LABOUR AND DELIVERY............................................................................................................................... 14
2.9 CARE OF THE INFANT AND POST-PARTUM CARE ..................................................................................... 15
STATEMENT OF INTENT .................................................................................................................... 16
3. REFERENCES ............................................................................................................................................... 17
4. ADDITIONAL REFERENCES .................................................................................................................. 19
APPENDIX I: Minimum Data Set for audit of the care of pregnant women with epilepsy....................... 25
2